172@29@16@18!~!172@29@0@53!~!|company-article|cipla|news|C!~!www|moneycontrol|com!~!|stocks|company_info|stock_news.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 30, 10:01
763.45
1.55 (0.2%)
VOLUME 16,114
LIVE
NSE
Oct 30, 10:01
763.00
0.7 (0.09%)
VOLUME 751,380
News on Cipla
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cipla gets into COVID-19 testing, with the launch of antibody test kits

6.38 pm | 28 Oct 2020 |  Source: Moneycontrol.com

The company has partnered with KARWA under the technology transfer from the Indian Council of Medical Research (ICMR)....

WHO Solidarity trial finds Remdesivir has no substantial effect on mortality in COVID-19 patients

8.50 am | 16 Oct 2020 |  Source: Moneycontrol.com

The results of the Solidarity trial conducted on 11,266 hospitalised patients in 30 countries found remdesivir, along with three other repurposed drug...

Reduce Cipla; target of Rs 657: Prabhudas Lilladher

11.49 am | 14 Oct 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended Reduce rating on Cipla with a target price of Rs 657 in its research report dated October 13, 2020....

Covid medicines help Cipla, Glenmark post strong sales growth in a subdued pharma market

3.46 pm | 13 Oct 2020 |  Source: Moneycontrol.com

The recovery was led by easing of lockdown restrictions and resumption of non-Covid related treatments....

Cipla gets final nod from USFDA for multiple sclerosis drug

11.17 am | 25 Sep 2020 |  Source: PTI

The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc''s Tecfidera....

Cadila: a formidable play in Covid times and beyond

9.39 am | 25 Sep 2020 |  Source: Moneycontrol.com

Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space w...

Cipla share price gains 4% on USFDA approval for multiple sclerosis drug

9.38 am | 25 Sep 2020 |  Source: Moneycontrol.com

The product is available for shipping immediately and the company will provide co-pay assistance....

Neutral Cipla; target of Rs 790: Motilal Oswal

6.59 pm | 11 Aug 2020 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 790 in its research report dated August 08, 2020....

Buy Cipla; target of Rs 805: HDFC Securities

6.58 pm | 11 Aug 2020 |  Source: Moneycontrol.com

HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 805 in its research report dated August 10, 2020...

Reduce Cipla; target of Rs 657: Prabhudas Lilladher

4.16 pm | 11 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended reduce rating on Cipla with a target price of Rs 657 in its research report dated August 09, 2020....

Buy Cipla; target of Rs 900: ICICI Direct

1.01 pm | 10 Aug 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 900 in its research report dated August 09, 2020....

Cipla Standalone June 2020 Net Sales at Rs 3,128.02 crore, down 3.14% Y-o-Y

9.33 am | 10 Aug 2020 |  Source: Moneycontrol.com

NULL...

Prospects for US business and leadership in respiratory therapies make Cipla attractive

8.15 am | 10 Aug 2020 |  Source: Moneycontrol.com

Cipla's US revenues clocked a sequential improvement to about $135 million, backed by a ramp-up in the generic version of gProventil HFA...

Accumulate Cipla; target of Rs 804: Dolat Capital

9.17 pm | 09 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended accumulate rating on Cipla with a target price of Rs 804 in its research report dated August 09, 2020....

Buy Cipla; target of Rs 875: Sharekhan

4.37 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 875 in its research report dated August 07, 2020....

Cipla Q1 profit jumps 27% YoY to Rs 566 crore, beats analysts' expectations

9.19 pm | 07 Aug 2020 |  Source: Moneycontrol.com

The North America business fell 9 percent YoY but grew 19 percent sequentially to Rs 1,021 crore in Q1 FY21...

Buy Cipla target of Rs 738: Anand Rathi

3.09 pm | 28 May 2020 |  Source: Moneycontrol.com

Anand Rathi is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 738 in its research report dated May 28, 2020....

Cipla Consolidated March 2020 Net Sales at Rs 4,376.19 crore, down 0.63% Y-o-Y

9.16 am | 21 May 2020 |  Source: Moneycontrol.com

NULL...

Buy Cipla; target of Rs 655: HDFC Securities

5.02 pm | 18 May 2020 |  Source: Moneycontrol.com

HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 655 in its research report dated May 16, 2020....

Buy Cipla; target of Rs 670: ICICI Direct

4.59 pm | 18 May 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 670 in its research report dated May 18, 2020....

1 2 3
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.